Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

TGFbeta Induction in Tumors

ABSTRACT: TGFb1 has both tumor suppressive and pro-oncogenic functions in cancer pathogenesis but the underlying basis of this not well understood. We have developed a transgenic conditional epidermal expression model for TGFb1 in order to examine its immediate effects in benign and malignant chemically induced squamous cancers. The microarray study is an attempt to elucidate those genetic changes contributing to this behavior. Keywords: compound treatment design

ORGANISM(S): Mus musculus

PROVIDER: GSE4195 | GEO | 2006/02/09

SECONDARY ACCESSION(S): PRJNA95047

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Expression data from intestinal organoids altered for Tgfbeta signaling

Project description:We treated intestinal organoids continuously for 5 days with or without TgfbR1/2 inhibitor (LY2109761) or Tgfb1 ligand

2014-06-09 | GSE58296 | GEO

Gold Compound Induces Immune Suppression via AHR-TGF-β1 Signaling

Project description:Gold compounds containing planar N-heterocyclic (NHC) carbene ligands are potent aryl hydrocarbon receptor (AHR) ligands. Further studies with the lead compound (called MC3), show that MC3 activates TGFβ signaling while repressing CD4+ T-cell activation in vitro, in human and mouse T-cells, and in scurfy mouse, while repression of AHR activity or TGFβ-SMAD cascades compensated its immune suppressive function. The in-vivo induction of Tgfb1 expression was associated with reduced severity of the autoimmune markers.

2019-01-16 | GSE125146 | GEO

Expression data from human intestinal enteroids altered for Tgfbeta signaling

Project description:We treated intestinal enteroids continuously for 6 days with or without TgfbR1/2 inhibitor (LY2109761) or Tgfb1 ligand

2016-06-17 | GSE83423 | GEO

Transforming growth factor-B1 drives differentiation of the embryonic jejunum

Project description:Transcription profiling by microarray was performed to pinpoint the roles of transforming growth factor B1 (TGFB1) in embryonic differentiation of the small intestine. An organ culture system in which mouse jejunal rudiments were placed on semipermeable platforms and fed with chemically defined serum-free media, supplemented with two concentrations of TGFB1.

2017-04-03 | E-MTAB-4509 | biostudies-arrayexpress

Expression data from intestinal organoids altered for Tgfbeta signaling

Project description:We treated intestinal organoids continuously for 5 days with or without TgfbR1/2 inhibitor (LY2109761) or Tgfb1 ligand Organoids were continuously treated for 5 days, then RNA was extracted and hybridized to Affymetrix Mouse Genome 430 2.0

2014-06-09 | E-GEOD-58296 | biostudies-arrayexpress

Mus musculus

Project description:Expression data from chemically-induced skin papillomas (benign tumours)

| PRJNA240864 | ENA

Dnmt3a associates with promoters and enhancers to protect epidermal stem cells from cancer [RNA-seq]

Project description:The de novo DNA methyltransferase Dnmt3a is mutated in human acute myeloid leukemia, and suppresses tumorigenesis in murine models of leukemia and lung cancer. Conversely, deregulation of the other de novo DNA methyltransferase, Dnmt3b, predominantly promotes tumorigenesis. However, the molecular mechanisms underlying the roles of Dnmt3a and Dnmt3b in cancer remain poorly understood. Using conditional knockout mice, here we show that Dnmt3a -- but not Dnmt3b -- strongly protects epidermal stem cells from carcinogen-induced tumor initiation, without affecting the progression of benign lesions to aggressive carcinomas. Only upon combined deletion of Dnmt3a and Dnmt3b, squamous cell carcinomas acquired a more aggressive fate and even became metastatic, indicating that Dnmt3b is tumor-suppressive, rather than pro-tumorigenic, in epidermal neoplasia. Mechanistically, Dnmt3a promotes the expression of epidermal differentiation genes by interacting with their enhancers, and inhibits the expression of lipid metabolism and cell proliferation genes by directly methylating their promoters. Altogether, we demonstrate that Dnmt3a, but not Dnmt3b, is critical for suppressing epidermal tumor initiation, while both enzymes prevent tumor progression.

2020-04-07 | GSE92423 | GEO

Dnmt3a associates with promoters and enhancers to protect epidermal stem cells from cancer [ChIP-seq]

2017-06-13 | GSE92421 | GEO

Dnmt3a associates with promoters and enhancers to protect epidermal stem cells from cancer [MeDIP-seq]

2020-03-26 | GSE92422 | GEO

Gene expression during transdifferentiation of bovine ear fibroblasts into adipocytes induced by small molecule compounds

Project description:To investigate the molecular mechanism of small molecule compound-induced transdifferentiation of bovine fibroblasts into adipocytes, we established direct conversion of bovine ear fibroblasts (BearFs) into the chemically-induced adipocytes (CiADCs) using three Small Molecular Compound.

2023-02-22 | GSE215910 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data